CN102977105A - Synthesis method of 3(methyl),7-diazabicyclooctane - Google Patents
Synthesis method of 3(methyl),7-diazabicyclooctane Download PDFInfo
- Publication number
- CN102977105A CN102977105A CN2012105000348A CN201210500034A CN102977105A CN 102977105 A CN102977105 A CN 102977105A CN 2012105000348 A CN2012105000348 A CN 2012105000348A CN 201210500034 A CN201210500034 A CN 201210500034A CN 102977105 A CN102977105 A CN 102977105A
- Authority
- CN
- China
- Prior art keywords
- methyl
- limited
- degree
- aluminium hydride
- lithium aluminium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The invention discloses a synthesis method of 3(methyl),7-diazabicyclooctane. Aiming at the defects that the traditional synthesis method of 3(methyl),7-diazabicyclooctane has low reaction yield, requires strict conditions and does not easily realize purification, the invention proposes a way of performing addition ring closing between 1-methylpyrrole-2,5-diketone serving as a start raw material and nitromethoxymethylbenzyltrimethylsiliconmethylammonia and reducing with lithium aluminum hydride and finally performing debenzylation to obtain 3(methyl),7-diazabicyclooctane. According to the synthesis method disclosed by the invention, the whole process has high yield and is easy to operate, the product is easy to purify, and column chromatography is avoided; and the method is suitable for industrialization, and the cost of raw materials is greatly reduced.
Description
Technical field
The present invention relates to the 3(methyl), synthesizing of 7-diazabicyclo octane also relates to the synthetic of its intermediate and uses, and belongs to medical, chemical technology field.
Background technology
The 3(methyl), 7-diazabicyclo octane is important chemistry, chemical intermediate, be widely used in medicine and pesticide field, especially aspect antitumor and similar rheumatism new drug synthetic, be seen at present the analogue synthetic route of report seldom, and severe reaction conditions mostly, yield is low, is difficult for purifying, is difficult to industrialization.
Summary of the invention
The present invention is directed to the 3(methyl), 7-diazabicyclo octane synthetic method reaction yield in the past is low, condition is harsh, the deficiency that is difficult for purifying, invented described with 1-methylpyrrole-2, the 5-diketone is that ring is closed in starting raw material and the addition of n-formyl sarcolysine oxygen methyl-benzyl trimethyl silicane methyl ammonia, reduce last debenzylation with Lithium Aluminium Hydride again and obtain the 3(methyl), the route of 7-diazabicyclo octane makes whole process yield high, easy handling, the good purifying of product, avoid column chromatography, be fit to industrialization, raw materials cost reduces greatly.
Described 3(methyl), 7-diazabicyclo octane is synthetic, by 1-methylpyrrole-2, the 5-diketone is that starting raw material becomes (3) catalyst system therefor including but not limited to trifluoroacetic acid with n-formyl sarcolysine oxygen methyl-benzyl trimethyl silicane methyl ammonia addition pass cyclization, tosic acid, sulfuric acid, methylsulfonic acid etc., first-selected trifluoroacetic acid, solvent is including but not limited to tetrahydrofuran (THF), dioxane, methylene dichloride, ethylene dichloride etc., first-selected methylene dichloride, temperature of reaction is not limited to zero degree to 50 degree, first-selected 25 degree, and the time was not limited to 0.5 hour to 48 hours.
Described 3(methyl), 7-diazabicyclo octane is synthetic, revert to (4) reduction reagent including but not limited to Lithium Aluminium Hydride by intermediate (3), borine dimethyl sulphide, sodium borohydride/aluminum chloride, first-selected Lithium Aluminium Hydride, temperature of reaction is not limited to 25 degree to 100 degree, first-selected 65 degree, and the time is not limited to half an hour to 72 hour, first-selected 24 hours, wherein aftertreatment destruction Lithium Aluminium Hydride method was the saturated sodium pyrosulfate aqueous solution.
Above-mentioned with 1-methylpyrrole-2, the 5-diketone is that the chemical reaction route of starting raw material is as follows:
Embodiment
Embodiment:
Preparation compound (3):
Starting raw material 1-methylpyrrole-2,5-diketone 222 grams (2.0 moles) are dissolved in 2.5 liters of methylene dichloride, add n-formyl sarcolysine oxygen methyl-benzyl trimethyl silicane methyl ammonia 522.3 grams (2.2 moles), 5 milliliters of trifluoroacetic acids (catalytic amount), add rear room temperature reaction 24 hours, reaction solution is transferred PH to 11, layering with the sodium hydroxide of 1N, the organic phase washing, the saturated salt washing, anhydrous sodium sulfate drying filters, be spin-dried for, re-crystallizing in ethyl acetate obtains beige solid 327.3 grams (yield 67%).
Preparation compound (4):
Compound (3) 244.3 grams (1.0 moles) that the upper step makes are dissolved in 2.5 liters of anhydrous tetrahydro furans, add Lithium Aluminium Hydride 159.6 grams (4.2 moles) in batches, add rear temperature rising reflux reaction 24 hours, be cooled to subzero 10 degree, the saturated sodium bisulfate about 1 of temperature control dropping is raised to does not have γ-ray emission, continues to stir 1 hour, filter, the tetrahydrofuran (THF) washing, anhydrous sodium sulfate drying is spin-dried for after the filtration and obtains oily matter 181.4 grams (yield 84%).
Preparation compound (5) is the 3(methyl), 7-diazabicyclo octane:
Compound (4) 108 grams (0.5 mole) that the upper step makes are dissolved in 1 liter of methyl alcohol, palladium carbon 10 grams of adding 10%, with reaction 48 hours under 2 atmospheric hydrogen environments 60 degree temperature behind the hydrogen exchange 3 times, cooled and filtered, methyl alcohol is washed, obtain yellow oil crude product 63 grams after being spin-dried for, dissolving crude product is in hydrogenchloride/methyl alcohol of 500 milliliters of 2N, stirred salify 1 hour, a large amount of solids are separated out, and filter and obtain pure product hydrochloride, and hydrochloride extracts after dissociating with the sodium hydroxide of 1N is molten, be spin-dried for and obtain pure 3(methyl), 7-diazabicyclo octane 47 grams (yield 74.6%).
Claims (3)
1. described with 1-methylpyrrole-2, the 5-diketone is that ring is closed in starting raw material and the addition of n-formyl sarcolysine oxygen methyl-benzyl trimethyl silicane methyl ammonia, reduce last debenzylation with Lithium Aluminium Hydride again and obtain the 3(methyl), the route of 7-diazabicyclo octane makes whole process yield high, easy handling, the good purifying of product, avoid column chromatography, be fit to industrialization, raw materials cost reduces greatly.
2. described 3(methyl), 7-diazabicyclo octane is synthetic, by 1-methylpyrrole-2, the 5-diketone is that starting raw material becomes (3) catalyst system therefor including but not limited to trifluoroacetic acid with n-formyl sarcolysine oxygen methyl-benzyl trimethyl silicane methyl ammonia addition pass cyclization, tosic acid, sulfuric acid, methylsulfonic acid etc., first-selected trifluoroacetic acid, solvent is including but not limited to tetrahydrofuran (THF), dioxane, methylene dichloride, ethylene dichloride etc., first-selected methylene dichloride, temperature of reaction is not limited to zero degree to 50 degree, first-selected 25 degree, and the time was not limited to 0.5 hour to 48 hours.
3. described 3(methyl), 7-diazabicyclo octane is synthetic, revert to (4) reduction reagent including but not limited to Lithium Aluminium Hydride by intermediate (3), borine dimethyl sulphide, sodium borohydride/aluminum chloride, first-selected Lithium Aluminium Hydride, temperature of reaction is not limited to 25 degree to 100 degree, first-selected 65 degree, and the time is not limited to half an hour to 72 hour, first-selected 24 hours, wherein aftertreatment destruction Lithium Aluminium Hydride method was the saturated sodium pyrosulfate aqueous solution.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105000348A CN102977105A (en) | 2012-11-30 | 2012-11-30 | Synthesis method of 3(methyl),7-diazabicyclooctane |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012105000348A CN102977105A (en) | 2012-11-30 | 2012-11-30 | Synthesis method of 3(methyl),7-diazabicyclooctane |
Publications (1)
Publication Number | Publication Date |
---|---|
CN102977105A true CN102977105A (en) | 2013-03-20 |
Family
ID=47851496
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2012105000348A Pending CN102977105A (en) | 2012-11-30 | 2012-11-30 | Synthesis method of 3(methyl),7-diazabicyclooctane |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102977105A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016078108A1 (en) * | 2014-11-19 | 2016-05-26 | 苏州乔纳森新材料科技有限公司 | Method for synthesizing 3-methyl-3,7-diazabicyclo[3.3.0]octane pharmaceutical intermediate |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050234031A1 (en) * | 2004-02-04 | 2005-10-20 | Schrimpf Michael R | Amino-substituted tricyclic derivatives and methods of use |
CN101189233A (en) * | 2003-09-19 | 2008-05-28 | 艾博特公司 | Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
-
2012
- 2012-11-30 CN CN2012105000348A patent/CN102977105A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101189233A (en) * | 2003-09-19 | 2008-05-28 | 艾博特公司 | Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
US20050234031A1 (en) * | 2004-02-04 | 2005-10-20 | Schrimpf Michael R | Amino-substituted tricyclic derivatives and methods of use |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016078108A1 (en) * | 2014-11-19 | 2016-05-26 | 苏州乔纳森新材料科技有限公司 | Method for synthesizing 3-methyl-3,7-diazabicyclo[3.3.0]octane pharmaceutical intermediate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103709121B (en) | The preparation method of pharmaceutical grade 2-benzothiazolyl mercaptan and derivative DM thereof | |
CN102633686A (en) | Preparation method of peramivir | |
CN102229613B (en) | New process for synthesis of asenapine | |
CN102584795A (en) | Preparing method of crizotinib | |
CN103030638B (en) | Preparation method of (S, S)-8H-6H-pyrrolo [3, 4-b] pyridine | |
CN102850325A (en) | Preparation method of Dabigatran etexilate key intermediate | |
CN103183673A (en) | Synthesizing method of (S,S)-2,8-diazabicyclo[4.3.0]nonane | |
CN102391128A (en) | Production method of antibiotic pharmaceutical intermediate mono-p-nitro benzyl malonate | |
CN104844593A (en) | Synthetic method for Apixaban drug intermediate | |
CN102977105A (en) | Synthesis method of 3(methyl),7-diazabicyclooctane | |
CN101215291B (en) | Synthesis method of (+)-biotin and its derivatives | |
CN102321045B (en) | Method for preparing high morphine hydrochloride | |
CN102603594B (en) | Preparation method of (S)-oxiracetam | |
CN102010428A (en) | Cefathiamidine compound and new preparation method thereof | |
CN102603595B (en) | Preparation method of (S)-oxiracetam | |
CN103923135B (en) | A kind of deuterated 5-hydroxyl color D-glucosamine glycoside derivates and preparation method thereof | |
CN101088999A (en) | Process of synthesizing 3-amino quinine dihydrochloride | |
CN107955020B (en) | Method for synthesizing benzimidazol oxazinone compound by copper salt catalysis in one pot | |
CN103664743B (en) | The preparation method of (3S, 4R)-3-amido-4-methyl piperidine-1-carboxylic acid tert-butyl ester | |
CN112062705A (en) | Synthesis method of 7-methyltryptophan | |
CN101486696B (en) | Preparation of 2,5-dimethyl furan-3,4-dicarboxylic acid | |
CN101486694B (en) | Preparation method of 2,5-dimethyl furan-3,4-dicarboxylate | |
CN102977104A (en) | Synthesis of 2,4-dichloro-7-hydroxy-pyrrolo(2,3)pyrimidine | |
CN111187223B (en) | Synthetic method of linagliptin intermediate 2-chloromethyl-4-methyl quinazoline | |
CN109776610A (en) | Chiral P based on phenyl ethylamine skeleton, N, N ligand class compound and preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130320 |